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Abstract
Stroke is the primary cause of disability due to the brain’s limited ability to regenerate damaged 
tissue. After stroke, an increased inflammatory and immune response coupled with severely 
limited angiogenesis and neuronal growth results in a stroke cavity devoid of normal brain tissue. 
In the adult, therapeutic angiogenic materials have been used to repair ischemic tissues through the 
formation of vascular networks. However, whether a therapeutic angiogenic material can 
regenerate brain tissue and promote neural repair is poorly understood. Here we show that the 
delivery of an engineered immune-modulating angiogenic biomaterial material directly to the 
stroke cavity promotes tissue formation de novo, resulting in axonal networks along generated 
blood vessels. This regenerated tissue produces functional recovery through the established axonal 
networks. Thus, this biomaterials approach generates a vascularized network of regenerated 
functional neuronal connections within previously dead tissue, laying the groundwork for the use 
of angiogenic materials to repair other neurologically diseased tissues.
The lack of an effective medical therapy that promotes long-term recovery after stroke 
represents a substantial clinical burden, establishing a need for a medical treatment outside 
the confines of conventional therapies1. In the developing body, angiogenesis pioneers a 
vascular network that leads to the growth and maturation of the nervous system2. 
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Angiogenesis after stroke is associated with better outcomes in stroke patients1 and 
promotes the formation of neurons through an endogenous neural stem cell response (post-
stroke neurogenesis)3, 4. However, therapeutic manipulation of angiogenesis is problematic 
in the brain. The most dominant angiogenic growth factor, vascular endothelial growth factor 
(VEGF), is associated with an increase in blood brain barrier (BBB) opening, brain edema, 
and neurological deficits5. Other attempts at stimulating brain angiogenesis to promote 
recovery in stroke have also not been successful6. We sought to determine if a therapeutic 
angiogenic material, delivering an engineered presentation of VEGF directly to the stroke 
cavity, could stimulate angiogenesis and accompanying tissue repair after stroke.
Stroke causes tissue damage and the formation of a cavity. In this cavity, there is no 
extracellular matrix that supports cell infiltration into the lesion or to physically support a 
growing tissue7. Indeed, there is a glial barrier to cell entry8. Stroke also stimulates a 
massive local inflammatory response that may impede recovery9. Over time the cavity 
reorganizes into a fibrotic scar devoid of neural tissue10. Yet, the stroke cavity represents a 
potential transplant location because it can accept a large volume of injection without 
affecting normal brain11, 12, 13, 14. In addition, the delivery of therapies to the stroke cavity 
targets the area adjacent to stroke, the peri-infarct area, the site of the most robust neuronal 
and vascular plasticity after stroke15. A successful strategy for brain repair after stroke 
would deliver a molecule that stimulates angiogenesis and neural regeneration, reduces local 
inflammation, removes the barrier to cellular infiltration in the stroke site, and introduces a 
scaffold that can serve as a physical support onto which a neuronal network can grow. 
Recent advances in biopolymer hydrogels have developed materials with extracellular 
matrix motifs that directly support survival and cell infiltration16, 17. Given that the brain 
extracellular matrix is composed mostly of glycosaminoglycans and is devoid of fibrous 
extracellular matrix components18, we chose to use an amorphous non-fibrous hydrogel 
composed of hyaluronic acid, which has been shown to promote neural differentiation19, to 
serve as the backbone into which a VEGF delivery system would serve as the initial physical 
support for infiltrating cells, angiogenesis and axonogenesis. We have previously published a 
hydrogel-encapsulating soluble BDNF that aimed at promoting axonal ingrowth within the 
damaged site independently of a vascular route20. The results showed modest behavioral 
improvement and no tissue regeneration within the lesion site.
Injectable hydrogel for brain repair
An in situ gelling hyaluronic acid hydrogel (Supplementary Fig. 1, Supplementary Fig. 2a) 
that is both hyaluronidase degradable and MMP degradable (Supplementary Fig. 1, 
Supplementary Fig. 2a) was selected as the scaffold in which to build an artificial 
extracellular matrix to promote brain repair after stroke. Injection into the stoke cavity and in 
situ gelation 5 days after stroke did not significantly affect the cortex volume, size or shape 
compared to the contralateral side at 2-weeks post-stroke (Supplementary Fig. 3), indicating 
that the injection volume (6μL) and crosslinked hydrogel could be accommodated by the 
stroke cavity. Furthermore, injection of this hydrogel resulted in statistically decreased 
astrocyte activation (Supplementary Fig. 4) compared to a sham condition. However, this 
decrease in astrocyte scar thickness was not accompanied with an increase in brain repair as 
measured by angiogenesis, axonogenesis, and behavioral improvement, indicating that 
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additional factors are required. We previously investigated slow VEGF release formulations 
(Supplementary Fig. 5) and shown that while there is an increase in vascularization and 
pericytes within the stroke cavity, this formulation did not result in improved neuronal tissue 
repair, indicating that in the context of stroke, sustained release of VEGF is not sufficient to 
promote neurological tissue repair.
Heparin nanoparticles alter the inflammatory and glial environment after 
stroke
We designed heparin nanoparticles so that they retained their ability to bind growth factors 
21
, including VEGF, but did not retain the native heparin ability to reduce blood coagulation 
(Supplementary Fig. 6). The dominant post-stroke inflammatory response of the brain is 
defined by the activation and recruitment to the damaged site of macrophages and 
microglia9. The initial extent of stroke damage correlates with intensity of microglia/
macrophage activation in peri-infarct tissues22. HA gel + nH injection into the stroke cavity 
in distal MCAo significantly decreases microglial/macrophage levels (measured by IBA-1 – 
Ionized calcium-binding adapter molecule 1) as compared to empty gel or sham controls 
(Supplementary Fig. 4). The decrease in markers of inflammation was accompanied by a 
significantly increased vascularization within the stroke cavity and the peri-infact area (Fig. 
1a–d, Fig. 2a,b,d) and an increase in immature neuron (DCX – Doublecortin positive) cell 
number (Fig. 3c). Recent evidence indicates that astrocyte activation in stroke and CNS 
lesions occurs in direct response to initial damage and restricts this damage23, 24, providing a 
barometer of the evolving ischemic injury. nH significantly reduces the region of reactive 
astrocytes around the stroke cavity (Supplementary Fig. 4b). These gels do not modify the 
size of the stroke lesion itself (Supplementary Fig. 3d), suggesting that nH gel delivery to the 
stroke cavity reduces measures of long term damage in the tissue bordering the infarct. 
However, there was no difference of in-growth of axons within or around the stroke cavity in 
this condition.
VEGF clusters differentially activate endothelial cells
The HA gel was further engineered to promote angiogenesis. VEGF, bound to the 
extracellular matrix, signals through the clustering of VEGF receptors leading to sustained 
VEGF receptor-2 activation and altered downstream signaling compared to non-matrix 
bound VEGF25. Increasing ligand avidity through ligand clustering can enhance cellular 
activation, producing a more controlled tissue morphogenesis than with soluble factors26. 
Different clustering densities of VEGF were synthesized: low (lcV), medium (mcV) and 
high cluster (hcV, Supplementary Fig. 1, 2a–d). All VEGF clustering densities promoted the 
same level of endothelial cell proliferation (Supplementary Fig. 2e); however, VEGF 
receptor-2 (VEGFR-2) activation was significantly different between the different VEGF 
clustering densities. Y1175 and Y1214 in VEGFR-2 are major phosphorylation sites and we 
have previously shown differential activation upon presentation with bound or soluble 
VEGF27. These sites are also associated with the activation of the downstream signaling 
MAP kinases Erk1/2 (p42/44) and p3828. Phosphorylation at Y1175 and Y1214 by clustered 
VEGF displayed statistically higher phosphorylation for hcV than mcV or lcV 
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(Supplementary Fig. 2f–h, p < 0.05) in response to a 5-min exposure to nH bound VEGF. 
There was no statistically significant difference between hcV and soluble VEGF (Vs) 
phosphorylation at Y1175 or Y1214. Interestingly, although no differences in downstream 
signal activation were observed for the different clustered VEGF presentations, there were 
differences when compared to Vs-induced activation: soluble VEGF preferentially activated 
p42/44, while clustered VEGF preferentially activated p38. The differences in downstream 
signal are reminiscent of what was observed for collagen bound and heparin bound VEGF 
versus soluble VEGF29, 30, 31, indicating that VEGF bound to nH respond similarly to 
VEGF bound to bulk matrices.
hcV results in long-term revascularization of the stroke cavity
The brain tissue response to the angiogenic biomaterial (HA gel + hcV) was assessed after 
injection into the stroke cavity in distal MCAo 5-days post stroke (Supplementary Fig 1). 
Angiogenesis was measured at 2- and 16-weeks post stroke, representing a vessel maturation 
period and chronic period in tissue and behavioral recovery in stroke, respectively. At 2-
weeks after stroke mice injected with HA gel containing the high clustered VEGF condition 
(HA gel + hcV) significantly increased endothelial cell area and proliferation (Glut-1 – 
Glucose transporter 1) and pericyte (PDGFR-β – Platelet-derived growth factor receptor-β) 
area in and around the stroke cavity (Fig. 1a–f) compared to HA gel containing the low 
VEGF cluster (lcV), nanoparticles only (nH), soluble VEGF (Vs) or HA gel only. Heparin 
nanoparticle-only group also outperformed every other group but was significantly lower 
than the hcV condition hcV. Since VEGF delivery to the brain has previously been 
associated with immature vessels, lacking pericyte coverage32, we tested whether 
endothelial and pericyte markers were colocalized. We found that HA gel + hcV stimulated 
vascular structures with pericyte coverage (Fig. 1f). In addition, the quantification of 
Angiopoietin-2, known to play a distinct role in angiogenesis and in coupling of 
angiogenesis to other elements of tissue repair33, showed a significant increase in the peri-
infarct area in the hcV brain compared with the No gel and gel + Vs conditions, in the close 
vicinity of vessels (Supplementary Fig. 7).
Therapeutic angiogenic materials often have a short-term angiogenic response that subsides 
and vessels regress as the angiogenic stimulus (e.g. VEGF) is depleted34. HA gel + hcV 
resulted in a significantly increased vascular area inside the stroke cavity while no 
significant difference between groups was observed in the peri-infarct area (Fig. 2a,b). 
Inside the infarct, the increased angiogenesis led to a vascular area greater than the 
contralateral side, indicating a vascular network that is more substantial than the original 
network in this cortical area. After stroke, the normal process of angiogenesis leads to a 
tortuous and dilated vasculature31. We assessed the vascular tortuosity, branching points, 
vessel diameter and infiltration distance within the infarct cavity of the induced vessels35 
compared to normal vessels in the contralateral side at the 16-week time point. HA gel + 
hcV showed a lower degree and variability of vessel tortuosity and was closer to the 
tortuosity of normal vessels (Fig. 2c(1). There was no significant difference in the number of 
vascular ramifications between groups (Fig. 2d(1). Finally, the stroke cavity with HA gel + 
hcV displayed a significantly reduced vascular diameter compared with HA gel + soluble 
VEGF (Fig. 2c(2), with a value close to the contralateral normal control side and a 
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significantly greater vascular infiltration distance into the lesion site compared with any 
other group (Fig. 2d(2).
Interestingly, while no effect on blood-brain barrier (BBB) permeability was observed at the 
2-week time point (Supplementary Fig. 4), a significantly increased infarct size was found in 
the Vs condition (Supplementary Fig. 3), consistent with previous reports that soluble VEGF 
administration in stroke may worsen stroke outcome36. This increased stroke volume 
observed in the Vs condition 2 weeks after stroke is maintained at 16 weeks post-stroke 
(Supplementary Fig. 8).
Revascularization of the stroke cavity leads to neurogenesis and 
axonogenesis
We tested the hypothesis that by promoting a dense and well-formed vascular bed inside the 
stroke cavity, the development of an accompanying neural structure would follow. 
Neurogenesis after stroke occurs to a limited degree as neuroblasts migrate from their origin 
in the subventricular zone to areas of damage. Neurogenesis in the present experiments was 
assessed by staining neuroblasts (Dcx) 10-days or 16 weeks after gel transplantation in distal 
MCAo stroke. The number of proliferative neuroblasts (Dcx/BrdU - Bromodeoxyuridine) 
was significantly increased in the hcV compared with the No gel control group (Fig. 3c). 
The total number of Dcx cells in the SVZ was also significantly increased in both the HA 
gel + hcV and HA gel + nH conditions compared with any other group. Similarly, these two 
conditions display a significantly increased number of Dcx cells along the corpus callosum, 
the migratory path towards the lesion, compared with any other group, with no significant 
difference in the migrating distance (Fig. 3d). These results may be due to the increased 
angiogenic signal in HA gel + hcV and HA gel + nH conditions (Fig. 1d), or due to 
reductions in tissue barriers at this site. The addition of VEGF did not change the 
inflammatory response to HA gel + nH, which continued to have significantly reduced the 
microglial positive area and astrocytic scar thickness compared with mice injected with low 
cluster VEGF (Gel + lcV), soluble VEGF (Gel + Vs), Empty gel and No gel control 2 weeks 
after stroke (Supplementary Fig. 4, 8). This early increase in immature neurons in the peri-
infarct cortex was not sustained: at 16 weeks there were no significant differences between 
groups in the number of Dcx cells (Supplementary Fig. 9). This data suggests that the 
presence of naked heparin particles found in both gel + nH and gel + hcV conditions induces 
migration of immature neuroblasts into the damaged tissue adjacent to the stroke cavity at 
initial stages during tissue recovery after stroke.
We next determined if angiogenesis could promote the infiltration of axons into the stroke 
lesion site as it does in the normal body during development37. Three separate assessments 
were performed to assess axonogenesis at 2- and 16-weeks utilizing a marker for axons, 
neurofilaments (NF200 – Neurofilament 200) and assessing its density in the infarct and 
peri-infarct areas, neurofilament infiltration distance, and neurofilament infiltration angle (a 
measure of the orientation of the axonal network). At both 2 weeks (Fig. 3e,f) and 16 weeks 
after stroke (Fig. 3h–j), only the hcV had significantly more neurofilament area compared 
with the other conditions. These axons had a significantly deeper axonal infiltration distance 
Nih et al. Page 5
Nat Mater. Author manuscript; available in PMC 2018 November 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
into the infarct, and a penetrating angle that is similar to the angle measured between the 
NF200 axons and the cortex in the contralateral side (Fig. 3k) which suggests that the 
formed axonal network in the hcV condition is a structured in a similar linear pattern to the 
normal cortical axonal network. Interestingly at 16 weeks the NF200 positive area in the 
high cluster VEGF condition is higher than the contralateral value (dotted line) in the 
homologous cortex that is not affected by stroke (Fig. 3h,i) indicating that similar to the 
formed vasculature in the hcV-treated brains, the axonal ingrowth into the stroke cavity 
establishes a network of connections that is greater than the underlying brain structure of 
cortex.
To further study the connection of the vascular network with the formed axonal network, we 
co-stained vessels (Glut-1) and neurofilament networks (NF200) at 16-weeks. We found a 
very close association between the vessels and neurofilaments in the hcV brains (Fig. 4a,b) 
with a statistically higher percent of neurofilaments that are either in direct contact with 
(Fig. 4c) or within 50μm of a vessel (Fig. 4d), further confirming the role of vessels in 
forming a reparative neurovascular niche that leads to axonogenesis within the stroke cavity.
To prove that the observed axonogenesis was due to the revascularization of the stroke cavity 
and not a direct effect of VEGF on sprouting neurons38, 39, we blocked angiogenesis through 
a VEGF independent mechanism using endostatin during days 5 to 15 after stroke and 
analyzed the neurofilament network at 16 weeks. This approach blocks angiogenesis in this 
stroke-hydrogel-VEGF approach40. We found a significant reduction of the vascular area 
(Supplementary Fig. 10a), growth (Supplementary Fig. 10b) and infiltration (Supplementary 
Fig. 10c) of endostatin-injected HA + hcV mice at 16 weeks post-stroke. The blockade of 
angiogenesis in HA gel + hcV mice is associated with a statistical reduction of the axonal 
network area in and around the stroke (Fig. 4a,b), particularly in the vicinity of vessels (Fig. 
4c), indicating that angiogenesis is causally linked to the axonogenesis observed in the hcV 
condition. These results show that inducing angiogenesis into the infarct can generate an 
elaborate neuronal architecture within this normally fibrotic cavity. In order to identify the 
neuronal population that sends axonal projections to the stroke site of gel + hcV –treated 
mice, we delivered BDA (biotinylated dextran amine), a marker for bidirectional axonal 
tracing in the gel injection coordinates on Week 16 after gel treatment (Fig. 4d). BDA uptake 
was visualized fluorescently using a streptavidin-fluorochrome detection. Brain sections 
were co-stained with the astrocytic marker GFAP – Glial fibrillary acidic protein (in order to 
visualize the site of lesion. We found that neurons sending axonal projections in the injected 
cavity of hcV mice are located in the in the ipsilateral peri-infarct cortex, with a clear 
detection of retrogradely traced cell bodies up to 800μm distant from the site of injection.
Last, we aimed to determine whether the formed vasculature in the gel + hcV brains present 
characteristics of functional maturity with both coverage with pericytes (PDGFR-β, Fig. 4e) 
and astrocytic endfeet (Aquaporin-4, Fig. 4f). Fluorescent staining shows a strong vascular 
coverage with both pericytes and end-feet astrocytes, associated with GFAP-expressing 
astrocyte cell bodies in the vicinity of vessels, further indicating that in this condition, 
normal brain architecture is achieved.
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From a therapeutic angiogenic material to a functional axonal network
In order to test whether the induced vascular and neuronal tissue in the stroke cavity is 
associated with functional recovery, behavioral recovery was measured after hydrogel 
transplantation. Photothrombotic stroke in the forelimb motor cortex causes limb use deficits 
in mice for at least 16 weeks after the infarct41. Mice received this stroke and were 
transplanted 5 days later with HA gel, HA gel + Vs, HA gel + lcV and HA gel + hcV (Fig. 
5a). Limb control was measured with 3 different behavioral tests every 4 weeks for 16 
weeks, in order to assess the dexterity of the contralateral forelimb (Cylinder test/asymmetry 
score, Fig. 5b(1), hindlimb (Grid test/footfault, Fig. 5b(2) and forepaw (Pasta test/paw 
adjustment and time in seconds, Fig. 5b(3–4) in measures that reflect human motor control 
patterns after stroke42. Stroke causes a deficit in limb motor control in exploratory rearing, 
gait and dexterous forepaw use that is maximal at 4 and 8 weeks after the infarct with some 
recovery but still a persistent deficit at 12 and 16 weeks. HA gel + hcV-injected animals 
displayed a significantly increased use of their contralateral forelimb in exploratory rearing 
in the cylinder task beginning 12 weeks after stroke (Fig. 5b(1), and a significant decrease in 
the number of contralateral footfaults on the grid walk task at the same point (Fig. 5b(2). 
The pasta handling test showed the HA gel + hcV condition produced a significantly 
reduced time to manipulate and eat a piece of pasta on weeks 8 to 16 (Fig. 5b(3), while 
showing a significantly increased use of contralateral digits in handling the pieces of food 
(Fig. 5b(4). No other gel or VEGF condition was associated with this degree of enhanced 
functional recovery. These results indicate a dramatic decrease in limb use deficits for high 
cluster VEGF condition, suggesting that the axonal network observed in HA + hcV delivery 
is functionally active.
To prove that the observed functional recovery was linked to angiogenesis due to the formed 
axonal network in the stroke cavity, we performed two separate tests. First, we used 
endostatin to block angiogenesis as previously done (Supplementary Fig. 10). Since 
blocking angiogenesis significantly reduced neurofilament density and infiltration distance 
(Fig. 3g–j), blocking angiogenesis should also prevent the functional improvement observed 
if the formed axonal network or vascular network are responsible for the observed 
improvement. Treatment with endostatin impaired the recovery observed in the high cluster 
VEGF condition, showing a significantly decelerated recovery compared with the HA gel + 
hcV animals, and this in all the behavioral tasks performed (Fig. 5c(1–4), demonstrating that 
VEGF induced angiogenesis is critical in the observed functional recovery. To test if the 
enhanced functional recovery in the HA + hcV condition was due to the axonal connections 
observed in the infarct (Fig. 5d(1–4), we retrogradely transfected the neurons that extend 
these axons into the infarct (Fig. 4a,d) by injecting an AAV construct that expresses a 
neuronal silencing receptor, hM4D DREADD43 directly into the infarct site. Neurons that 
form connections into the damaged tissue and the HA gel + hcV gel will be inhibited when 
CNO, the ligand for hM4D, is administered. This technique has been used to silence 
neuronal activity in a specific area of rodent brain43. At week 13, a time period of enhanced 
motor recovery in HA gel + hcV, neurons that project into the hcV gel were silenced with 
CNO (Fig. 5a). Initially, HA gel + hcV treated stroke animals showed enhanced functional 
recovery, replicating the earlier results of this gel. However, when these animals were treated 
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with CNO, the improved motor functions were lost and the animal deficit was worsened 
(Fig. 5d(1–4), demonstrating that the formed axonal network is responsible for the observed 
functional improvement. In total, these studies indicate HA gel + hcV promotes 
development of a neurovascular brain tissue within a normally fibrotic scar and promotes 
functional recovery through angiogenesis and stimulated axonal ingrowth into a network of 
connections from adjacent brain.
Naked heparin particles are essential for the pro-repair properties of hcV
The injected high and low cluster treatments (respectively hcV and lcV) were designed to 
contain equal amounts of heparin and VEGF (Supplementary Fig. 1). Though we showed 
that heparin particles have a reduced blood thinning ability compared to polymeric heparin 
(Fig. 6, Supplementary Fig. 11), the introduction of naked heparin particles to the hcV group 
complicates clinical translation. Thus, we wanted to determine if the delivery of high cluster 
VEGF alone would perform similarly as high cluster VEGF + heparin nanoparticles. We 
injected mice with gels containing only heparin particles coated with VEGF at high cluster 
density and removed the unloaded naked particles (hcV-nH). The results showed that 
similarly to the hcV treatment, the hcV-nH treatment enhanced post-stroke angiogenesis at 2 
weeks (Fig. 6a,b). This pro-angiogenic effect was maintained in the peri-infarct 16 weeks 
after stroke (Supplementary Fig 11a,b). However, the increase in angiogenesis was 
accompanied with an increase in inflammation (Fig. 6a,c), characteristic of VEGF delivery 
in brain and other organ systems44. Both microglia area and glial scar thickness were 
significantly increased in the hcV-nH condition compared with hcV, showing an 
inflammation worse than in the empty gel control group (Fig. 6e). Further, no axonal growth 
was observed in this group (Fig. 6d). The pro-inflammatory effect of the hcV – nH was also 
observed at 16 weeks, where the microglia area and the scar thickness was maintained 
significantly higher than in hcV (Supplementary Fig 11c,e).
The results obtained with the hcV-nH conditions show that axonal formation that follows 
therapeutic angiogenesis requires immune-modulation of injury-induced inflammation. The 
absence of post-stroke immune-modulation results in vasculature that is not followed by 
tissue repair. Similarly, we tested whether the addition of naked heparin particles to lcV, a 
VEGF cluster group that did not show pro-repair effect in the brain, would increase its 
beneficial effects. This experimental condition, lcV + nH, was tested for the same repair 
characteristics at 2 (Fig. 6) and 16 weeks (Supplementary Fig. 11). The results show that the 
lcV + nH treatment did not promote vascular (Fig. 6b) or axonal growth (Fig. 6d), did not 
reduce the microglial inflammation (Fig. 6C) or the scar thickness (Fig. 6e) 2 weeks after 
stroke. The same results were observed at 16 weeks post-stroke (Supplementary Fig 11a–d). 
The results obtained with lcV + nH show that the combination of VEGF and naked particles 
is not enough to promote brain repair, as the therapeutic effect of heparin particles is only 
observed with high VEGF clusters.
To investigate the effect of heparin nanoparticles on inflammatory and anti-inflammatory 
cytokine levels after stroke, a multiplex ELISA was performed. Mice were stroked and 
injected with gel + nH five days post stroke. Three and 10 days after gel transplantation, the 
infarct core with the injected gel were harvested and quantified for their levels of cytokines 
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(TNF-α, IL-6, IFN-γ, IL-1 α, IL-1 β, IL-2, IL-4 and IL-10). We found that gel + nH 
significantly decreased brain concentration of TNF-α 3 days after the gel injection (P 
=0.0076). At this time point, gel + nH does not show any significant difference with the No 
stroke condition (Supplementary Fig. 12, Supplementary notes 2).
Conclusion
The stroke cavity is a fibrotic region devoid of neurons and with a sparse, disordered 
vasculature. The cavity represents the tissue lost after stroke and is associated with 
functional disability in stroke patients. This report shows that engineering a VEGF-
containing hydrogel biomaterial and injecting it directly within the stroke cavity induces the 
formation of a vascular and neuronal structure that leads to behavioral improvement. The 
HA gel + hcV induce the formation of a robust, mature and highly developed vascular bed 
within the stroke cavity and patterned axonal ingrowth along these vessels. This vascular bed 
is mature as compared to the normal vascular structure in cortex in its morphology and 
pericyte coverage. This is unexpected in a traditional delivery of VEGF in the brain32 and 
indicates that the clustered nanoparticle presentation of VEGF in the hydrogel promotes 
elements of normal vascular development. This distinctive vascular development in 
hydrogel-presented nanoparticle-clustered VEGF is supported by the differential VEGFR2 
phosphorylation and downstream p38 signaling of clustered VEGF. This hydrogel also 
modifies the adjacent peri-infarct tissue, by reducing microglia activation, the size of the 
reactive astrocyte border and by promoting in-migration of immature neurons from the 
subventricular zone. HA + hcV hydrogels promote vascular in-growth into the infarct cavity 
and an accompanying axonal network. These formed axons inside the stroke cavity are 
tightly physically associated with the generated vascular network, and selective blockade of 
vascular in-growth blocks the development of this axonal network inside the cavity. These 
findings support a process of coordinated vascular and axonal growth in a developing neural 
tissue inside a normally fibrotic brain scar. In the developing body, and particularly in skin, 
development of the vascular and neuronal networks are tightly coordinated through shared 
molecular signaling systems, such as Slits, semaphorins, netrins and VEGF45. In the present 
study, co-delivery of nanoparticle-clustered VEGF and heparin nanoparticles were sufficient 
to induce this ingrowth and co-patterning of vascular and neuronal systems, but is likely to 
have done so by initiating a process that may be locally sustained by these other signaling 
systems.
Although the anti-coagulant properties of heparin are well established, increasing evidence 
indicates that heparin presents many anti-inflammatory effects linked to its ability to block 
leucocyte adhesion to the vessel wall46 and to stabilize chemokine and growth factor 
gradients47, but also act as a reservoir of heparin binding cytokines48. Here, we hypothesize 
that the immuno-modulation properties of naked particles result from its ability to bind and 
decrease brain levels of stroke-induced pro-inflammatory cytokine TNF-α directly at the 
lesion site. Moreover, the high inflammation found in lcV, where all heparin particles are 
bound to VEGF, further indicates that the anti-inflammatory properties of heparin particles 
are exclusively observed in their un-bound state. VEGF delivery has been associated with 
increased inflammation, which lowers efficacy and increases adverse effects44. Here we 
show that naked heparin particles, can counter balance the inflammatory effect of VEGF and 
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lead to the formation of a pro-repair environment that leads to brain tissue formation de 
novo.
Injection of a hydrogel into the stroke cavity has been tested in large animal stroke models20, 
and provides a tractable way to approach the post-infarct brain without damaging or 
manipulating viable tissues around the infarct, which are a site of substantial repair15. This 
combination of direct production of a neurovascular structure in the infarct cavity and 
modulation of inflammatory, scar and neural stem cells responses in the adjacent brain 
position this approach as unique in the field of neural repair.
Materials and Methods
Heparin nanoparticle synthesis and VEGF binding
Heparin (from porcine intestinal mucosa, Alfa Aesar) was modified with p-azidobenzyl 
hydrazide (ABH) as previously described49. The remaining carboxylic acid groups on 
heparin were then conjugated with N-(3-Aminopropyl) methacrylamide in 27 molar excess 
through EDC coupling chemistry overnight in PBS buffer, dialyzed against distilled (DI) 
water, and lyophilized. The final product was dissolved in a 100 mg/ml solution of sodium 
acetate at pH 4, mixed with Tween-80 and Span-80 (8% HLB) and sonicated to form 
nanoparticles. A radical polymerization was initiated as previously described 49. A total 
concentration of 20μg/ml VEGF (Genentech, Telbermin) was mixed with concentrations of 
heparin nanoparticles ranging from 0.1 to 0.001 mg/mL to form different packing densities 
of VEGF onto the particle’s surface, incubated overnight and exposed to UV light (365 nm) 
for 10 minutes to covalently bind VEGF to heparin particles. The VEGF nanoparticles were 
washed from excess with 0.05% Tween-20, then with PBS, using a 100 kD MWCO dialysis 
units. The washes were collected and an Elisa and Dot blot were performed to estimate the 
amount of VEGF bound to nanoparticles by subtracting the washes to the total amount of 
VEGF mixed.
Heparin nanoparticle characterization
Dynamic Light Scattering (DLS) was used to characterize the Z-average (diameter) and 
polydispersity index (PDI) of heparin nanoparticles after each preparation step. Samples 
were analyzed by a Malvern Zetasizer where ten runs of three measurements each were 
performed. In order to confirm the results obatiend by DLS, Transmission Electron 
Microscopy (TEM) with a T12 Quick CryoEM was performed on heparin particles (1 
mg/mL) using a carbon-coated copper grid (300 mesh). The nanoparticles were negatively 
stained by 2 wt % photungstic acid (PTA) solution.
Enzyme linked immunosorbant assay (ELISA) and Dot Blot
The amount of VEGF immobilized onto nanoparticles in the different clustering conditions 
was measured using a standard ELISA technique as previously described50. A Dot blot was 
also realized in order to confirm the Elisa results: a 2μl drop of the sample was deposited on 
a nitrocellulose membrane. A blocking buffer of BSA (1% in PBS) was used before adding 
the biotinylated detection antibody, followed by streptavidin-HRP. The samples were then 
visualized using chemifluorescence (ECL detection reagents, GE Healthcare) using a 
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Molecular Imager Chemi Doc XRS+ scanner (Bio Rad). The stained membrane images were 
analyzed with Image Lab software.
VEGFR-2 phosphorylation assay
Human Umbilical Vein Endothelial Cells (HUVECs, LONZA, CC-2519) were cultured as 
previously described29.
RNA Isolation and Real Time q-PCR
HUVECs were grown up to 70% confluency in complete EGM media (Lonza, Switzerland). 
Cells were submitted to serum depravation for 5 h., before exposing them to fetal bovine 
serum basal EGM-2 media at different time points (2, 4, 6 h). Cells were trypsinized and the 
cell pellet was collected. Lysis buffer from the RNAqueous micro total RNA isolation kit 
(Ambion, Life Technologies) was immediately added to cell pellet. RNA concentration was 
evaluated by UV absorbance (λ = 260 nm). Reverse transcription was carried out by loading 
0.25 μg RNA per reaction of the iScript Advanced cDNA synthesis kit (Bio-Rad). 
Quantitative real-time PCR (qPCR) was carried out using 10 ng cDNA per reaction of the 
Maxima SYBR Green/ROX qPCR master mix (Thermo Scientific, Pittsburgh, PA, USA) 
following the manufacturer’s recommended protocol for three-step cycling using the 
StepOnePlus real-time PCR system (Applied Biosystems, Life Technologies). Every 20-μl 
reaction contained 5μl of cDNA, 12.5 μl SYBR Green master mixes (life technology), 250 
nM forward, reverse primers, and nuclease free water. Threshold cycles (CT) were evaluated 
by the bundled software and expression fold change was calculated using the delta-delta CT 
method assuming 100% efficiency. GAPDH was used as the housekeeping gene.
Proliferation assay
Proliferation rate of HUVEC cells exposed to different clusters of VEGF was evaluated 
using a Cell Proliferation Assay Kit (CyQUANT®, Invitrogen). Briefly, cells were grown in 
complete EGM-2 media in a 96 well-plate for 2–4 hrs for cell attachment and exposed to 
VEGF nanoparticle of different cluster density, in basal EBM media with 2% fetal bovine 
serum (Lonza, Basal, Switzerland) and compared to a negative control condition containing 
no VEGF. After 2 days of culture, cells were lysed and the relative fluorescence was 
measured at 485 nm excitation and 528 nm emissions. The data are expressed as relative 
fluorescence to a condition where cells were exposed to only heparin particles only.
Tail vein bleeding assay
C57BL/6 male mice of 8–12 weeks (Jackson Laboratories) were put under isoflurane 
anesthesia (2–2.5% in a 70% N2O/30% O2 mixture), then placed on a warming pad and 
injected intravenously with heparin, heparin particles or saline (4 U/kg, 50 μl). Thirty 
minutes later, the lateral vein was incised transversally over a position corresponding to a 
diameter of 2.5 mm. The tail is then immersed in warm PBS (37°C) in a conical tube until 
the vein stops bleeding (tail vein bleeding time, in seconds).
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Hyaluronic acid modification and hydrogel gelation
Hyaluronic acid (60,000 Da, Genzyme, Cambridge, MA) was functionalized as previously 
described13.
Gelation
The hydrogel was made as previously described53. We have previously found that clustered 
bioactive signals such as the adhesion peptide RGD results in significant differences in cell 
behaviour when encapsulated inside three-dimensional HA 53. The highest degree of cell 
spreading, integrin expression and proliferation of encapsulated mouse mesenchymal stem 
cells was obtained with a ratio of 1.17 mole of RGD-reacting HA for 1 mole of RGD. The 
RGD peptide was dissolved in 0.3 M HEPES and added to 16% of the total HA-AC required 
to obtain a degree of clustering of 1.17, and reacted for 20 minutes at room temperature 
before being added to the rest of non-RGD reacting HA-AC. A total of 200 ng of soluble 
(Gel + Vs) or heparin nanoparticle-bound VEGF 165 (Gel + hcV, Gel + lcV) was added to 
the gel precursor solution.
Animal experiment design
Animal procedures were performed in accordance with the US National Institutes of Health 
Animal Protection Guidelines and approved by the Chancellor’s Animal Research 
Committee as well as the UCLA Office of Environment Health and Safety. C57BL/6 male 
mice of 8–12 weeks (Jackson Laboratories), were used in the study. Two stroke models were 
performed: A permanent and distal Middle cerebral artery occlusion (MCAo) and photo-
thrombotic (PT). The MCAo model closely simulates human ischemic stroke and its peri-
infarct penumbra54 as approximately 70% of human infarcts originate from the MCA. In 
addition, this model is considered suitable for the study of ischemia-induced cell death, 
inflammation, and blood–brain barrier (BBB) damage in the brain, and has therefore been 
used in the majority of studies that address post-stroke repair mechanisms such as 
neurogenesis and angiogenesis55. This model was chosen for the 2 week time point in order 
to evaluate the effect of the gel + hcV treatment on vascularization. However, because the 
permanent and distal MCAo model doesn’t induce a long-term neurological deficit, the PT 
model was used to assess the neurological deficit for 16 weeks.
Middle Cerebral Artery Occlusion (MCAO) stroke model
MCAo model was induced under 2% anesthesia by exposing and occluding by 
electrocoagulation the anterior branch of the distal left MCA through a craniotomy over the 
parietal cortex. The MCAo-induced ischemic cellular damage is localized on the 
somatosensory and motor cortex56 and was chosen because of the high re-vascularization 
process after stroke in this region57, 58.
Photothrombotic (PT) stroke model
The PT stroke was induced using a intraperitoneally-injected light-sensitive dye as 
previously described59. Briefly, mice were positioned in a stereotaxic instrument and 
administered Rose Bengal (10 mg/ml, i.p.) and the closed skull at the stereotaxic coordinate 
1.5 mm medial/lateral was illuminated with a white light for 18 minutes.
Nih et al. Page 12
Nat Mater. Author manuscript; available in PMC 2018 November 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hydrogel and VEGF intracranial transplantation
Five days following stroke surgery, 6 μL of RGD – functionalized HA hydrogel containing 
the different forms of VEGF was injected directly into the stroke cavity through a 30-gauge 
needle attached to a 25 μL Hamilton syringe (Hamilton, Reno, NV). A syringe pump 
maintained the infusion rate at 1 μL/min in the following coordinates anterior-posterior (AP) 
= 0.26 mm, medial-lateral 60 = 3 mm, and dorso-ventral (DV) = 1 mm and 1.5 mm for 
MCAo and PT mice, respectively. Control group were injected with an empty RGD-
functionalized gel (Empty gel). This time point for VEGF injection was selected according 
to published literature on on the time frame of VEGF up-regulation in the stroke brain and 
the peak of peri-infarct microvascular density61. Ten days following hydrogel 
transplantation, animals were injected intraperitoneally with the 5-bromo-2′-deoxyuridine 
(BrdU, Sigma, St Louis, MO) at a concentration of 100 mg/kg, 4 and 2 hours before 
euthanasia to assess cell proliferation.
Mouse tissue processing and immunohistochemistry
At 2 weeks post-stroke (10 days after transplantation), mice were transcardially perfused 
with 40 mL of 4% (wt/vol) paraformaldehyde (PFA). Brains were harvested and post-fixed 
in 4% PFA overnight and immersed in 30% sucrose for 2 days for cryoprotection. Tangential 
sectioning of frozen brains (30 μm-thick) were obtained using a cryostat and placed on 
gelatin-coated glass slides. Immunohistochemistry includes washing steps using PBS and 
permeabilization/blockage using Triton (0.3% ) and Normal Donkey Serum (10% ). Primary 
antibodies were as follows: Rabbit anti-Glucose Transporter 1 (Glut-1-) (1:200; Abcam, 
Cambridge, MA) for vascular Endothelial Cells; goat anti- Platelet-derived Growth Factor 
Receptor β (1:400; PDGF-Rβ, R&D Systems, Minneapolis, MN) for pericytes; goat anti-
doublecortin (DCX) (C18, 1:500; Santa Cruz Biotechnology, Santa Cruz, CA) for 
subventricular neural progenitor cells; rat anti-BrdU (1:300; Abcam, Cambridge, MA); rat 
anti-GFAP (1:400; Zymed, San Francisco, CA) for astrocytes; rabbit anti-microglial-specific 
ionized calcium binding adaptor molecule 1 (Iba-1) (1:250; Wako Pure Chemical Industries, 
Japan) for microglial cells; rabbit anti-Neurofilament 200 (NF200) (1:100; Sigma-Aldrich, 
St Louis, MO), mouse anti-Angiopoietin-2 (1:100; Abcam, Cambridge, MA), rabbit anti-
Aquaporin-4 (1:250; Abcam, Cambridge, MA). Primary antibodies were incubated 
overnight at +4°C followed by fluorescently labeled secondary antibody (1:1000; Jackson 
Imuno-research, West Grove, PA, USA) for 1 h at room temperature. Cell nuclei were 
labeled using DAPI (4′, 6-diamidino-2-phenylindole, (DAPI, 1:2000, Invitrogen) for 10 
minutes, followed by a step of dehydration in ethanol, and dewaxing in xylene. For BrdU 
staining, sections were incubated with 2N HCl and sodium borate buffer (pH 8.4) before 
addition of the primary antibody62.
Microscopy and Morphoanalysis
Analyses were performed as previously described63. The scar thickness was measured on the 
ischemic boundary zone within the ipsilateral hemisphere on 3 sections stained for GFAP. 
The NF200 infiltration within the ischemic core represents the average of the length of 
axonal sprouts penetrating in the infarct area. The Dcx migration was measured on the 
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ipsilateral hemisphere and represents the length of migration of Dcx positive neuroblasts 
along the Corpus Callosum.
Assessment of Infarct, hemispheres and cortex volume
Quantification of infarct, ipsilateral and contralateral hemispheres and cortex was performed 
using a upright Leica DMLB microscope (Microbrightfield hardware and software, 
Williston, VT, USA). For each animal, every 10th coronal sections were stained for NeuN 
and Dapi and digitized using Stereo Investigator (Microbrightfield). The volumes were 
calculated by combining the measured areas with the section thickness. All values obtained 
were averaged and represented as one single value per animal.
Evaluation of Blood-Brain Barrier (BBB) permeability
BBB permeability was evaluated as previously described 40. The absorbance of the solution 
was measured at 625 nm. A ratio absorbance ipsilateral/contralateral was obtained and 
expressed as unit/g dry weight as previously described64.
Endostatin treatment
Endostatin (Recombinant mouse, 100 μg/ml; Alpha Diagnostic, San Antonio, TX), a VEGF-
independent angiogenesis inhibitor, was injected subcutaneously daily during days 5–15 
after stroke to hcV-treated mice. hcV-Endostatin mice were submitted to behavioral tests and 
their brain used for immunohistology at 16 weeks time point.
AAV5 brain injection
An additional set of hcV-injected mice were injected at week 13 after stroke with a viral 
construct AAV5 construct expressing hM4 DREADD receptors (designer receptors 
exclusively activated by a designer drug), capable of silencing transfected neurons after 
attachment to an i.p administered drug clozapine-N-oxide (CNO) on week 16. A total 
volume of 1 μL of AAV5 was injected in the stroke site at an infusion rate of 0.1 μL/min. 
The AAV5 vector as a tool to study the direct association between brain activity in the 
infarcted zone and the behavioral outcome. Indeed, the CNO/DREAAD system was shown 
to inhibit the action potential (AP) of transfected cells through the activation of Inwardly 
Rectifying K+ channels, provoking a massive entrance of K+ ions and a subsequent 
hyperpolarization of the cell 65. Thus the administration of CNO inhibits the 
neurotransmitter transport within the injected site, here the infarcted area, 30 minutes after 
injection and remains active for a period of 2 hours without compromising cells integrity. A 
behavioral test was then be performed within the AP silent window, to assess whether hcV-
induced axons in the stroke site participate to the behavioral outcome.
BDA brain injection
A total volume of 1 μL of BDA (biotinylated dextran amine), an efficient and powerful 
marker for bidirectional axonal tracing, was injected in the stroke site at an infusion rate of 
0.1 μL/min, in gel + hcV –treated mice, 16 weeks after stroke. Mice were sacrificed 5 days 
later and BDA staining was visualized fluorescently by immunohistology using a one-step 
streptavidin-fluorochrome detection.
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Cytokine analysis
Animals were stroked and injected with gel + nH five days later. The contralateral brain at 
10-days (no stroke) and stroke only served as positive and negative controls, respectively. At 
3 and 10 days after gel transplantation, animals were placed under anesthesia and perfused 
intracardially with PBS to flush out blood. Harvested brains were dissected and the infarct 
core with the injected gel were dissected and homogenized. A total of 1.5 mg/mL of sample 
was then diluted 1:1 with PBS+ 0.5% fetal bovine serum and quantified for their levels of 
cytokines using a multiplex Elisa analysis through the Bio-Plex kit (Bio-rad Laboratories 
Inc.) for the following cytokines: TNF-α, IL-6, IFN-γ, IL-1 α, IL-1 β, IL-2, IL-4 and IL-10.
Behavioral deficit assessment
The cylinder test / spontaneous forelimb task and the Grid-walking test were performed as 
previously described59. For the pasta test, mice were submitted to food restriction 1 day 
prior to the test, then placed in a cylinder and were given a total number of 4 pieces of 
uncooked vermicelli (7 cm length, 1.5 mm diameter; De Cecco Capellini), once piece at a 
time and videotaped while eating. A total of 3 criterias were quantified: 1) number of 
adjustments (release-regrasp) per forepaw per piece of pasta. 2) The time to eat one piece of 
pasta (in secondes). 3) Atypical pasta handling behaviors as previously described41.
Statistics
Statistical analyses were performed as previously described 63 for both histology (minimum 
n=5) and behavioral tests (n=12). For endostatin –related analysis, two-tailed unpaired test 
was used for the comparison of two groups (hcV and hcV + endostatin). The results are 
expressed as mean ± SEM. Single, double, triple and quadruple asterisks represent P <0.05, 
P <0.01, P <0.001 and P <0.0001, respectively. A P value < 0.05 was considered statistically 
significant. The BDA axonal tracing, histology for vascular coverage at 16 weeks and 
characterization of heparin particles by TEM were repeated independently three times with 
similar results.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Post-stroke angiogenic response and vascular remodeling
(A) Fluorescent images of vessels (Glut-1) with Dapi, (B) a marker of proliferation (BrdU), 
and (C) pericyte/smooth muscle cells (PDGFR-β) in and around the stroke site (*) at day 10 
after gel transplantation. Quantification of the vascular density (% Glut-1 area) in the infarct 
(D1) and peri-infarct (D2), angiogenesis (Glut-1/BrdU cells) in the infarct (E1) and peri-
infarct (E2) and pericyte vascular coverage (% PDGFR-β area) in the infarct (F1) and peri-
infarct area (F2). No gel = stroke only condition, empty gel = HA hydrogel, gel + Vs = HA 
hydrogel loaded with 200ng of soluble VEGF, gel + nH = HA hydrogel with 1μg heparin 
nanoparticles (nH), gel + lcV = HA hydrogel with 1μg nH loaded with 200 ng VEGF, gel + 
hcV = HA hydrogel with 0.01 μg nH loaded with VEGF and 0.99 μg unloaded nH. Data is 
presented using a min to max box plot. Each dot in the plots represents one animal and p 
values were determined by One-way ANOVA with a Tukey’s post-hoc test, with *, ** and 
**** indicating p < 0.05, p < 0.01 and p < 0.0001, respectively. Scale bar: 100 μm.
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Figure 2. Long-term post-stroke vascular growth
(A) Fluorescent images of vessels (Glut-1) in and around the stroke site (*) 16 weeks after 
gel transplantation. (B) Quantification of the vascular density (% Glut-1 area) in and around 
the stroke site (*), Quantification of the vessel morphology: vessel tortuosity = total vessel 
length/shortest distance (C1) and diameter (C2), Quantification of vessel growth with 
number of ramifications = the number of branches/vessel (D1) and maximum infiltration 
distance of the vessels into the stroke site (D2). In all plots, the dotted red line and red 
number indicates the value for the give quantification of the contralateral side. Empty gel = 
gel = HA hydrogel, Vs = 200 ng of soluble VEGF, lcV = 1μg nH loaded with 200 ng VEGF, 
hcV = 0.01 μg nH loaded with VEGF and 0.99 μg unloaded nH. Data is presented using a 
min to max box plot. Each dot in the plots represents one animal and p values were 
determined by One-way ANOVA with a Tukey’s post-hoc test, with *, ** and **** 
indicating p < 0.05, p < 0.01 and p < 0.0001, respectively. Scale bar: 100 μm.
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Figure 3. Post-stroke neurogenesis and axonal sprouting
(A) Fluorescent images of neuroblasts (Dcx) and the proliferation marker BrdU, and (B) 
axonal neurofilaments (NF200) in and around the stroke site (*) at 2 weeks and (G) at 16 
weeks after gel transplantation. (C) Quantification of neuroblasts (Dcx) and proliferating 
neuroblasts (Dcx/BrdU) in the ipsilateral ventricle, (D) the number of neuroblasts migrating 
and their migration distance and number, (E) the axonal area (NF200) in and around the 
stroke site, and (F) infiltration distance and penetration angle in the stroke site. (H) 
Quantification of axonal area (NF200) in and (I) around the stroke site, (J) infiltration 
distance and (K) axonal penetration angle 16 weeks after gel injection. In all plots, the 
dotted red line and red number indicates the value for the give quantification of the 
contralateral side. Empty gel = gel = HA hydrogel, Vs = 200 ng of soluble VEGF, lcV = 1μg 
nH loaded with 200 ng VEGF, hcV = 0.01 μg nH loaded with 200 ng VEGF and 0.99 μg 
unloaded nH, Endo = a daily i.p injection of endostatin day 5 to 15. Data is presented using a 
min to max box plot. Each dot in the plots represents one animal and p values were 
determined by One-way ANOVA with a Tukey’s post-hoc test, with *, ** and **** 
indicating p < 0.05, p < 0.01 and p < 0.0001, respectively. Scale bar: 100 μm.
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Figure 4. Association between the vascular and axonal network in the lesion site
(A) Fluorescent images of vessels (Glut-1, red) and axonal neurofilaments (NF200, green) in 
and around the stroke site (*) 16 weeks after gel transplantation. (B) Quantitative assessment 
of the proximity between the 2 networks with the quantification of NF200 positive signal on 
vessels and (C) positive area a distance of 50 μm from vessels. (D) Fluorescent images of the 
peri-infarct astrocytic scar (GFAP, green) and BDA-traced neurons (red) in the ipsilateral 
hemisphere of gel + hcV injected mice 16 weeks after gel transplantation. (E) Fluorescent 
images of astrocytes (GFAP) co-stained with vessels (Glut-1) and pericytes/smooth muscle 
cells (PDGFR-β), or (F) with end-feet astrocytes (Aquaporin-4) in the stroke site of hcV-
treated mice, 16 weeks after gel transplantation. Empty gel = gel = HA hydrogel, Vs = 200 
ng of soluble VEGF, lcV = 1μg nH loaded with 200 ng VEGF, hcV = 0.01 μg nH loaded 
with 200 ng VEGF and 0.99 μg unloaded nH, Endo = a daily i.p injection of endostatin days 
5 to 15. Data is presented using a min to max box plot. Each dot in the plots represents one 
animal and p values were determined by One-way ANOVA with a Tukey’s post-hoc test, 
with ** and **** indicating p < 0.01 and p < 0.0001, respectively. Data represent the 
average. $$$ indicates p < 0.001 vs Gel+hcV. Scale bar: 100 μm.
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Figure 5. Post-stroke neurological recovery
(A) Experiment timeline for the behavioral tests. Mice were injected 5 days after stroke with 
one of the following treatments: empty gel, gel + Vs, gel + lcV, and gel + hcV. Mice were 
subjected to different behavioral tests (illustrated by vertical grey boxes on the timeline) On 
week 0, 1, 4, 8, 12 and 16 after stroke. (B1) The Cylinder test was used to measure the 
dexterity of their contralateral forelimb, (B2) the Grid test for the contralateral hindlimb, and 
(B3, B4) the Pasta test for the contralateral forepaw, normally sensitive to post-stroke 
lateralized impairments. (C1–C4) In order to determine the role of gel+hcV -induced 
vascularization on behavioral recovery, a supplemental set of gel+hcV animals was 
administered with endostatin, a VEGF-independent angiogenic inhibitor for 10 days after 
the gel injection, and submitted to the same behavioral tests: Cylinder (C1), Grid (C2), and 
Pasta (C3–C4). (D1–D4) In order to determine the role of gel+hcV –induced axonal growth 
on recovery, a supplemental set of gel+hcV animals received a brain injection of an AAV5 
viral construct expressing hM4 DREADD receptors (designer receptors exclusively activated 
by a designer drug) directly in the stroke area on week 13. Transfected neurons are silenced 
after i.p administration of the DREADD ligand, clozapine-N-oxide (CNO) on week 16. 
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Mice are then submitted to the same behavioral tests: Cylinder (D1), Grid (D2), and Pasta 
(D3–D4).
Empty gel = HA hydrogel, Vs = 200 ng of soluble VEGF, lcV = 2μg nH loaded with 200 ng 
VEGF, hcV = 0.01 μg nH loaded with 200 ng VEGF and 0.99 μg unloaded nH. Data 
represent the average ± SEM (n = 12 mice) and p values were determined by One-way 
ANOVA, Tukey’s post-hoc test, * indicating P < 0.05.
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Figure 6. Role of naked heparin particles in the hcV treatment at 2 weeks post-stroke
Since the injected high and low cluster treatments (respectively hcV and lcV) were designed 
to contain equal amounts of heparin and VEGF, the VEGF clusterization in the hcV 
treatment was obtained on a low amount of heparin, leaving a high amount of naked 
particles. In order to understand the contribution of these naked particles in the pro-repair 
effect of the hcV, two supplemental group were studied: the hcV – nH where the naked 
particles from the hcV were removed, and the LcV + nH where additional naked particles 
were added to the low VEGF cluster condition. (A) Fluorescent images of vessels (Glut-1), 
astrocytic scar (GFAP), microglia (Iba-1) and axonal neurofilaments (NF200) in and around 
the stroke site (*) of gel + (hcV – nH) and LcV + nH) conditions, 2 weeks post-stroke. 
Quantitative assessment of the vascular area in the infarct (B1) and the peri-infarct area 
(B2), microglial area in the infarct (C1) and the peri-infarct area (C2), axonal area in the 
infarct (D1) and the peri-infarct area (D2), axonal infiltration distance (E1) and astrocytic 
scar (E2) at 2 weeks post-stroke.
hcV – nH = 0.01 μg nH loaded with 200 ng VEGF, lcV = 1μg nH loaded with 200 ng VEGF 
and 0.99 μg unloaded nH. Data is presented using a min to max box plot. Each dot in the 
plots represents one animal and p values were determined by One-way ANOVA with a 
Tukey’s post-hoc test, with **, *** and **** indicating p < 0.01, p < 0.001 and p < 0.0001, 
respectively. Data represent the average. Scale bar: 100 μm.
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